RCA
Roberts Capital Advisors Portfolio holdings
AUM
$135M
This Quarter Return
+6.46%
1 Year Return
+28.82%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$119M
AUM Growth
+$119M
(+2.2%)
Cap. Flow
-$1.67M
Cap. Flow
% of AUM
-1.39%
Top 10 Holdings %
Top 10 Hldgs %
53.24%
Holding
89
New
–
Increased
2
Reduced
1
Closed
9
Top Buys
| 1 |
Lam Research
LRCX
|
$925K |
| 2 |
Invesco QQQ Trust
QQQ
|
$220K |
Top Sells
| 1 |
T Rowe Price
TROW
|
$554K |
| 2 |
Nike
NKE
|
$542K |
| 3 |
Target
TGT
|
$520K |
| 4 |
Regeneron Pharmaceuticals
REGN
|
$263K |
| 5 |
Advanced Micro Devices
AMD
|
$246K |
Sector Composition
| 1 | Technology | 48.16% |
| 2 | Consumer Discretionary | 12.52% |
| 3 | Communication Services | 11.3% |
| 4 | Financials | 10.6% |
| 5 | Industrials | 7.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Edwards Lifesciences
EW
$47.8B
| $310K | 0.26% |
4,192
| – | – |
|
77
Skyworks Solutions
SWKS
$11.1B
| $279K | 0.23% |
3,148
| – | – |
|
78
Gilead Sciences
GILD
$140B
| $270K | 0.23% |
2,920
| – | – |
|
79
Qorvo
QRVO
$8.4B
| $232K | 0.19% |
3,311
| – | – |
|
80
Vertex Pharmaceuticals
VRTX
$100B
| $231K | 0.19% |
574
| – | – |
|
|
81
Nike
NKE
$114B
| – | – |
-6,136
| Closed | -$542K |
|
|
82
Regeneron Pharmaceuticals
REGN
$61.5B
| – | – |
-250
| Closed | -$263K |
|
|
83
Advanced Micro Devices
AMD
$264B
| – | – |
-1,501
| Closed | -$246K |
|
84
Biogen
BIIB
$19.4B
| – | – |
-438
| Closed | -$84.9K |
|
85
Intel
INTC
$107B
| – | – |
-5,700
| Closed | -$134K |
|
86
Moderna
MRNA
$9.37B
| – | – |
-1,067
| Closed | -$71.3K |
|
|
87
Target
TGT
$43.6B
| – | – |
-3,334
| Closed | -$520K |
|
|
88
T Rowe Price
TROW
$23.6B
| – | – |
-5,084
| Closed | -$554K |
|
89
Veralto
VLTO
$26.4B
| – | – |
-1,341
| Closed | -$150K |
|